Please read and agree to the terms and conditions of this site.
@Sri_Baqri 4 years ago
A new @CellCellPress Special Review issue on #Therapeutics: #Cancer, #autoimmune #disease, #vaccines, #RareDisease #MachineLearning and #medicine, #CRISPR #AAV, #pharma #neurodegeneration - its all @ http://bit.ly/2V9mLV1 https://t.co/TXz3prO4yu
@xconomy.com 4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com 4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com 4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com 4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com 4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com 4 years ago
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September
@xconomy.com 5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com 5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
@Primary_Immune 6 years ago
To All Who Worked in the Past Year to Bring Medical Treatments and Cures...Thank You! #OpenScience #science #ChildhoodCancer #RareDisease #cancer #genetics #genomics #CRISPR #GeneTherapy #GlobalHealth #ITRTG #StemCell #biotech #pharma #BigData #SNRTG #research https://t.co/4WKLJdUWbE
@techcrunch.com 7 years ago
Reshaping human health and changing lives through gene editing